Amneal Pharmaceuticals's total assets for Q3 2025 were $3.60B, an increase of 5.17% from the previous quarter. AMRX total liabilities were $2.78B for the fiscal quarter, a -19.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.